Search - tctmd.com

Displaying 521 - 540 of 4231

Sort: Relevancy | Date

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

Presenter: Matthias Bossard

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Presentation TCT 2022

Drug Elution: Challenges and Opportunities

Presenter: Sahil Parikh

September 18, 2022

Presentation TCT 2022

Coronary DCB in HBR Patients: An Alternative to DES?

Presenter: Tuomas Rissanen

September 18, 2022

Presentation TCT 2022

Role of Drug-Eluting Technologies as Definitive Therapy

Presenter: Beau Hawkins

September 18, 2022

Presentation TCT 2022

Reflow Medical’s Temporary Spur DES System

Presenter: Jihad Mustapha

September 17, 2022

Presentation TCT 2022

MOTIV BRS (REVA Vascular)

Presenter: Christopher Metzger

September 17, 2022

Presentation TCT 2022

APTITUDE PLLA BRS (R3 Vascular)

Presenter: Mahmood K. Razavi

September 17, 2022

Presentation TCT 2022

Hybrid Nano-Coating DES for BTK Disease

Presenter: Terumitsu Hasebe

September 17, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Presentation TCT 2022

Conclusion

Presenter: Roxana Mehran

September 17, 2022

Presentation TCT 2022

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Presenter: Marie-Claude Morice

September 17, 2022

Presentation TCT 2022

Diabetes and DES+DCB platform: the perfect match

Presenter: Luca Testa

September 17, 2022

Presentation TCT 2022

The role of imaging in DM patients: case presentations from ABILITY RCT

Presenter: Antonio Mangieri

September 17, 2022

Presentation TCT 2022

The Innovative DES+DCB platform

Presenter: Fazila-Tun-Nesa Malik

September 17, 2022

Advertisement

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

DCB in CAD: understanding the existing and new indications

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Drug Elution: Challenges and Opportunities

Coronary DCB in HBR Patients: An Alternative to DES?

Role of Drug-Eluting Technologies as Definitive Therapy

Reflow Medical’s Temporary Spur DES System

MOTIV BRS (REVA Vascular)

APTITUDE PLLA BRS (R3 Vascular)

Hybrid Nano-Coating DES for BTK Disease

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Conclusion

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Diabetes and DES+DCB platform: the perfect match

The role of imaging in DM patients: case presentations from ABILITY RCT

The Innovative DES+DCB platform

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content